BioCorRx (BICX) Short term Debt (2015 - 2024)

BioCorRx (BICX) has 8 years of Short term Debt data on file, last reported at $1.2 million in Q3 2024.

• Quarterly Short term Debt changed N/A year-over-year to $1.2 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.2 million (changed N/A YoY) and the FY2023 annual result came in at $999088.0, changed N/A from the prior year.
• Short term Debt rose to $1.2 million in Q3 2024 per BICX's latest filing, from $865353.0 in the prior quarter.
• The five-year high for Short term Debt was $3.1 million in Q2 2022, with the low at $31580.0 in Q4 2021.
• Average Short term Debt over 5 years is $1.8 million, with a median of $2.3 million recorded in 2020.
• Year-over-year, Short term Debt grew 25.17% in 2020 and tumbled 98.68% in 2021.
• BioCorRx's Short term Debt stood at $2.4 million in 2020, then plunged by 98.68% to $31580.0 in 2021, then soared by 9721.92% to $3.1 million in 2022, then slumped by 67.79% to $999088.0 in 2023, then grew by 21.61% to $1.2 million in 2024.
• Business Quant data shows BICX's Short term Debt at $1.2 million in Q3 2024, $865353.0 in Q2 2024, and $80190.0 in Q1 2024.